With the small molecule outsourcing market expected reach $69.4 billion by 2024, Almac Pharma Services’ VP Technical Operations, John McQuaid, discusses some growing requirements he sees from Almac’s client base as the industry addresses some of the trends associated with small molecule drug development.
What are the major trends in small molecule drug development that you are currently seeing from your client base?